Wood anemone. Anemone Nemorosa L. Analytical review

Authors

DOI:

https://doi.org/10.15587/2519-4852.2017.104438

Keywords:

Ranunculaceae, Anemone nemorosa, Protoanemonin, biologically active compounds, pharmacological activity

Abstract

Literature sources were analyzed and the data concerning the range, biologically active compounds content and the use in pharmacy and medicine of Anemone nemorosa were summarized.

The aim of research is implementation of Anemone nemorosa in pharmaceutical and medical practice. Anemone nemorosa is a perennial herb of the buttercup (Ranunculaceae) family. This herb is non-officinal, but it is widely used in traditional medicine as an antitumor, anti-inflammatory, antispasmodic, sedative, diaphoretic, bactericidal, antimicrobial, antifungal, expectorant, and diuretic agent. The main biologically active substances of Anemone nemorosa are alkaloids, glycosides (Protoanemonin, Anemonin, Ranunculine, some types of saponins, tannins), vitamin C, resins, organic acids (chelidonic acid), coumarins, flavonoids and γ-linolenic acid.

The plant belongs to the regionally rare plants of Ukrainian administrative territories, therefore, despite the results of phytochemical and pharmacological studies, it becomes clear that the further use of Anemone nemorosa as a medicinal herb is an important issue for pharmacy and pharmaceutical biotechnology due to the prospects of research in area of new herbal remedies creation.

Due to extensive experience of use in traditional medicine, a wide range of pharmacological activity, the content of biologically active compounds, Anemone nemorosa is a promising and valuable herbal material for phytochemical remedies production and their practical implementation

Author Biographies

Anna Lukianchuk, Lviv Polytechnic National University Bandera str., 12, Lviv, Ukraine, 79013

Department of Technology of Biologically Active Substances, Pharmacy and Biotechnology

Oksana Khropot, Lviv Polytechnic National University Bandera str., 12, Lviv, Ukraine, 79013

Postgraduate student

Department of Technology of Biologically Active Substances, Pharmacy and Biotechnology

Yulian Konechnyi, Lviv National Medical University named after Danylo Galician Pekarska str., 69, Lviv, Ukraine, 79010

Internship doctor

Department of Microbiology, Virology and Immunology

Roksolana Konechna, Lviv Polytechnic National University Bandera str., 12, Lviv, Ukraine, 79013

PhD, Assistant

Department of Technology of Biologically Active Substances, Pharmacy and Biotechnology

Volodymyr Novikov, Lviv Polytechnic National University Bandera str., 12, Lviv, Ukraine, 79013

ScD, Professor, Head of Department:

Department of Technology of Biologically Active Substances, Pharmacy and Biotechnology

References

  1. Shavel, I. (2012). Tsilushchi roslyny Ukrainy [Healing plants of Ukraine]. Lviv: BaK, 432.
  2. Christopher, C. (2013). Encyclopedia of Cultivated Plants: From Acacia to Zinnia 3 Vol.: From Acacia to Zinnia. Santa Barbara, 1236.
  3. Grodzinskyi, A. M. (Ed.) (1992). Likarski roslyny: Entsyklopedychnyi dovidnyk [Encyclopedic Reference of medicinal plants]. Kyiv: Publishing "Ukrainian Encyclopedia" named after Bazhan M. P., 544.
  4. Kozoriz, O. (Ed.) (2007). Likarski roslyny Karpat. Dykorosli ta culturni. [Medicinal plants of the Carpathians. Wild and cultural]. Uzhgorod: Mystets'ka Liniya, 504.
  5. Zemlynskyi, S. E. (1952). Lekarstvennye rastenyia SSSR [Medicinal plants of the USSR]. Moscow: Publishing house of the Moscow Society of Naturalists, 507.
  6. Red Book of Ukraine (2010–2017). Available at: http://redbook-ua.org/
  7. Anemone (Wood) (1995–2017). Available at: http://Botanical.com/
  8. Mondoni, A., Probert, R., Rossi, G., Hay, F., Bonomi, C. (2008). Habitat-correlated seed germination behaviour in populations of wood anemone ( Anemone nemorosa L.) from northern Italy. Seed Science Research, 18 (4), 213–222. doi: 10.1017/s0960258508084997
  9. Hao, D.-C., Gu, X., Xiao, P. (2017). Anemone medicinal plants: ethnopharmacology, phytochemistry and biology. Acta Pharmaceutica Sinica, 7 (2), 146–158. doi: 10.1016/j.apsb.2016.12.001
  10. Tsevegsuren, N., Aitzetmuller, K. (1993). 7-Linolenic Acid in Anemone spp. Seed Lipids. Institute for Chemistry and Physics of Lipids, Federal Center for Cereals, Potato and Lipid Research (BAGKF), 28 (9), 841–846. doi: 10.1007/BF02536240
  11. Frohne, D., Pfander, H. J. (2005). Poisonous Plants: a handbook for doctors, pharmacists toxicologists, biologists and veterinarians. London: Manson Publishing Inc., 480.
  12. Minakata, H., Komura, H., Nakanishi, K., Kada, T. (1983). Protoanemonin, an antimutagen isolated from plants. Mutation Research/Genetic Toxicology, 116 (3-4), 317–322. doi: 10.1016/0165-1218(83)90069-1
  13. Martin, M., Roman, L., Dominguez, A. (1990). In VitroActivity of Protoanemonin, an Antifungal Agent. Planta Medica, 56 (1), 66–69. doi: 10.1055/s-2006-960886
  14. Bobadilla Fazzini, R. A., Skindersoe, M. E., Bielecki, P., Puchalka, J., Givskov, M., Martins dos Santos, V. A. P. (2012). Protoanemonin: a natural quorum sensing inhibitor that selectively activates iron starvation response. Environmental Microbiology, 15 (1), 111–120. doi: 10.1111/j.1462-2920.2012.02792.x
  15. Roth, L., Daunderer, M., Kormann, K. (2006). Poisonous plants-phytotoxins. Hamburg.
  16. Misra, S. B., Dixit, S. N. (1980). Antifungal principle ofRanunculus sceleratus. Economic Botany, 34 (4), 362–367. doi: 10.1007/bf02858312
  17. Maior, M., Dobrota, C. (2013). Natural compounds with important medical potential found in Helleborus sp. Open Life Sciences, 8 (3), 272–285. doi: 10.2478/s11535-013-0129-x
  18. Huang, Y.-H., Lee, T.-H., Chan, K.-J., Hsu, F.-L., Wu, Y.-C., Lee, M.-H. (2008). Anemonin is a natural bioactive compound that can regulate tyrosinase-related proteins and mRNA in human melanocytes. Journal of Dermatological Science, 49 (2), 115–123. doi: 10.1016/j.jdermsci.2007.07.008
  19. Hu, Y., Chen, X., Duan, H., Hu, Y., Mu, X. (2009). Pulsatilla decoction and its active ingredients inhibit secretion of NO, ET-1, TNF-α, and IL-1αin LPS-induced rat intestinal microvascular endothelial cells. Cell Biochemistry and Function, 27 (5), 284–288. doi: 10.1002/cbf.1570
  20. Duan, H., Zhang, Y., Xu, J., Qiao, J., Suo, Z., Hu, G., Mu, X. (2006). Effect of anemonin on NO, ET-1 and ICAM-1 production in rat intestinal microvascular endothelial cells. Journal of Ethnopharmacology, 104 (3), 362–366. doi: 10.1016/j.jep.2005.09.034
  21. Lee, T. H., Huang, N. K., Lai, T. C., Yang, A. T. Y., Wang, G. J. (2008). Anemonin, from Clematis crassifolia, potent and selective inducible nitric oxide synthase inhibitor. Journal of Ethnopharmacology, 116 (3), 518–527. doi: 10.1016/j.jep.2007.12.019
  22. Jia, D., Han, B., Yang, S., Zhao, J. (2014). Anemonin Alleviates Nerve Injury After Cerebral Ischemia and Reperfusion (I/R) in Rats by Improving Antioxidant Activities and Inhibiting Apoptosis Pathway. Journal of Molecular Neuroscience, 53 (2), 271–279. doi: 10.1007/s12031-013-0217-z
  23. Xiao, K., Cao, S. T., Jiao, L. F., Lin, F. H., Wang, L., Hu, C. H. (2016). Anemonin improves intestinal barrier restoration and influences TGF-β1 and EGFR signaling pathways in LPS-challenged piglets. Innate Immunity, 22 (5), 344–352. doi: 10.1177/1753425916648223
  24. Althea officinalis, Anemone nemorosa, Anemone sylvestris: Description of plants. Available at: http://ru.osvita.ua/vnz/reports/biolog/27498/
  25. Chekman, I. S. (2003). Klinichna phifoterapiia [Clinical phytotherapy]. Kyiv: A.S.K., 552.

Downloads

Published

2017-06-27

How to Cite

Lukianchuk, A., Khropot, O., Konechnyi, Y., Konechna, R., & Novikov, V. (2017). Wood anemone. Anemone Nemorosa L. Analytical review. ScienceRise: Pharmaceutical Science, (3 (7), 34–38. https://doi.org/10.15587/2519-4852.2017.104438

Issue

No. 3 (7) (2017)

Section

Pharmaceutical Science

License

Copyright (c) 2017 Anna Lukianchuk, Oksana Khropot, Yulian Konechnyi, Roksolana Konechna, Volodymyr Novikov

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons Attribution 4.0 International License copyright rights and permissions for open access journals.

Authors, who are published in this journal, agree to the following conditions:

1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.

 2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.

3. Authors have the right to store the final accepted version of the article in an institutional, thematic, or any other repository to ensure visibility and accessibility.